What is Cemiplimab: Uses, Dosage, Side Effects and More

Cemiplimab is a powerful cancer medication that helps your immune system fight certain types of skin cancer and lung cancer. It belongs to a group of medicines called immunotherapy drugs, which work by removing the brakes on your body's natural cancer-fighting abilities.

This medication is given through an IV infusion at a cancer treatment center or hospital. Your medical team will carefully monitor you throughout the treatment process to ensure you're getting the best possible care.

What is Cemiplimab?

Cemiplimab is a laboratory-made protein that mimics your body's natural immune system components. It's specifically designed to block a protein called PD-1, which cancer cells often use to hide from your immune system.

Think of PD-1 as a "stop sign" that tells your immune cells to back off. Cancer cells cleverly display signals that activate this stop sign, allowing them to grow unchecked. Cemiplimab blocks these signals, essentially removing the stop sign so your immune system can recognize and attack the cancer cells.

This medication is part of a revolutionary approach to cancer treatment called checkpoint inhibitor therapy. It's considered a strong and effective treatment option for patients whose cancers have specific characteristics that make them good candidates for this type of therapy.

What is Cemiplimab Used For?

Cemiplimab is primarily used to treat two main types of cancer: advanced cutaneous squamous cell carcinoma and certain types of lung cancer. Your doctor will determine if this medication is right for your specific situation based on several factors.

For skin cancer, cemiplimab helps treat cutaneous squamous cell carcinoma that has spread to other parts of your body or cannot be removed with surgery. This type of skin cancer is the second most common form of skin cancer, and cemiplimab offers hope when other treatments may not be suitable.

In lung cancer treatment, cemiplimab is used for non-small cell lung cancer that has spread and contains high levels of a protein called PD-L1. Your doctor will test your tumor tissue to see if it has these specific characteristics before recommending this treatment.

Less commonly, cemiplimab may be used for other types of cancer as part of clinical trials or special treatment programs. Your oncologist will discuss whether any of these options might apply to your situation.

How Does Cemiplimab Work?

Cemiplimab works by unleashing your immune system's natural power to fight cancer. It's considered a strong immunotherapy medication that can produce significant results, though it may take time to see the full effects.

Your immune system has built-in checkpoints that prevent it from attacking healthy cells. Cancer cells exploit these checkpoints by sending signals that say "don't attack me." Cemiplimab blocks one of these key signals, called the PD-1 pathway.

When cemiplimab blocks PD-1, your T-cells (a type of immune cell) can better recognize cancer cells as foreign invaders. This allows your immune system to mount a stronger attack against the tumor, potentially shrinking it or slowing its growth.

The medication doesn't work immediately like traditional chemotherapy. Instead, it may take several weeks or months for your immune system to fully respond. This delayed response is normal and doesn't mean the treatment isn't working.

How Should I Take Cemiplimab?

Cemiplimab is given as an intravenous (IV) infusion, which means it's delivered directly into your bloodstream through a vein. You'll receive this treatment at a cancer center or hospital where trained healthcare professionals can monitor you closely.

The typical treatment schedule involves receiving cemiplimab every three weeks. Each infusion takes about 30 minutes, though you may need to stay at the treatment center for additional observation time, especially during your first few treatments.

Before each infusion, your healthcare team will check your vital signs and may run blood tests to make sure your body is handling the treatment well. You don't need to fast before treatment, and you can eat normally on infusion days.

Your doctor might give you pre-medications before the infusion to help prevent allergic reactions. These are usually given through the same IV line and are a standard precaution, not a sign that something is wrong.

How Long Should I Take Cemiplimab For?

The length of cemiplimab treatment varies significantly from person to person, depending on how well the cancer responds and how your body tolerates the medication. Some people may receive treatment for several months, while others may continue for a year or longer.

Your doctor will regularly monitor your progress through scans, blood tests, and physical examinations. These check-ups help determine whether the treatment is working and whether you're experiencing any concerning side effects.

Treatment typically continues as long as the cancer is responding well and you're not experiencing serious side effects. If the cancer stops responding or if side effects become too severe, your doctor will discuss alternative treatment options with you.

In some cases, your doctor might recommend taking a break from treatment while still monitoring your condition closely. This approach, sometimes called a "drug holiday," can help your body recover from side effects while maintaining the benefits of the treatment.

What Are the Side Effects of Cemiplimab?

Cemiplimab can cause side effects because it activates your immune system, which may sometimes attack healthy parts of your body along with cancer cells. Most side effects are manageable with proper medical care, and many people tolerate the treatment well.

Understanding what to expect can help you feel more prepared and confident about reporting any changes to your healthcare team. Here are the most common side effects you might experience:

• Fatigue or feeling unusually tired
• Muscle or joint pain
• Skin rash or itching
• Diarrhea or changes in bowel movements
• Nausea or decreased appetite
• Cough or shortness of breath

These common side effects are generally mild to moderate and often improve as your body adjusts to the treatment. Your healthcare team has experience managing these effects and can provide strategies to help you feel more comfortable.

Some people may experience more serious side effects that require immediate medical attention. While these are less common, it's important to be aware of them:

• Severe skin reactions or widespread rash
• Persistent diarrhea or stomach pain
• Difficulty breathing or chest pain
• Changes in hormone levels affecting your thyroid, adrenal glands, or other organs
• Liver problems, which may cause yellowing of skin or eyes
• Kidney problems, which may cause changes in urination

Rare but serious side effects can include severe inflammation of organs like your lungs, liver, or intestines. Your healthcare team will monitor you carefully for these possibilities and can treat them effectively when caught early.

Who Should Not Take Cemiplimab?

Cemiplimab isn't suitable for everyone, and your doctor will carefully evaluate whether it's safe for you based on your medical history and current health status. Certain conditions may make this treatment too risky or less effective.

People with active autoimmune diseases may not be good candidates for cemiplimab because the medication can make these conditions worse. However, your doctor will consider the severity of your autoimmune condition and weigh it against the potential benefits of cancer treatment.

If you're pregnant or breastfeeding, cemiplimab is generally not recommended because it could harm your developing baby. Women who could become pregnant should use effective birth control during treatment and for several months after the last dose.

People with certain types of organ transplants may not be able to receive cemiplimab because it could cause their immune system to reject the transplanted organ. Your doctor will carefully consider all your medical conditions before recommending this treatment.

Cemiplimab Brand Names

Cemiplimab is sold under the brand name Libtayo in the United States and many other countries. This is the most common way you'll see it referenced in your treatment plans and medical records.

The full technical name is cemiplimab-rwlc, which helps distinguish it from other similar medications. When talking with your healthcare team or pharmacist, you can refer to it as either Libtayo or cemiplimab.

Different countries may have different brand names for the same medication, but the active ingredient cemiplimab remains the same. If you're traveling or moving, make sure to keep your medication information handy so healthcare providers can identify your treatment.

Cemiplimab Alternatives

Several other immunotherapy medications work similarly to cemiplimab, and your doctor might consider these alternatives depending on your specific type of cancer and medical situation. Each has its own benefits and considerations.

Pembrolizumab (Keytruda) is another PD-1 inhibitor that's used for many types of cancer, including some of the same cancers that cemiplimab treats. Your doctor might choose one over the other based on factors like your cancer type, previous treatments, and insurance coverage.

Nivolumab (Opdivo) is also a PD-1 inhibitor with a similar mechanism of action. It's approved for various cancers and might be an option if cemiplimab isn't suitable for you or if your cancer doesn't respond well to it.

Other treatment options might include traditional chemotherapy, targeted therapy drugs, or radiation therapy, depending on your specific situation. Your oncologist will help you understand all available options and choose the best approach for your individual case.

Is Cemiplimab Better Than Pembrolizumab?

Cemiplimab and pembrolizumab are both effective PD-1 inhibitors, but whether one is "better" depends on your specific cancer type, medical history, and individual response to treatment. Both medications work through the same mechanism and have similar success rates in many situations.

For cutaneous squamous cell carcinoma, cemiplimab was specifically studied and approved for this indication, making it a well-established choice. Pembrolizumab has a broader range of approved uses across many cancer types, which might make it more suitable for certain situations.

The side effect profiles of both medications are quite similar, though some people may tolerate one better than the other. Your doctor will consider factors like dosing schedule, potential drug interactions, and your insurance coverage when making recommendations.

Rather than focusing on which is "better," it's more helpful to think about which medication is most appropriate for your specific situation. Your oncologist has the expertise to guide this decision based on current research and your individual needs.